Stay updated with the latest news and articles about Sun Pharma.
Sales of Sun Pharma's formulations in India increased 5.1% to ₹3,560.4 crore. US formulation sales reached $471 million, a 12% YoY increase. More over one-third of the company's total consolidated sales came from sales in the US.
Top stocks to watch are Sun Pharma, Alembic Pharma, BEL, Crompton Greaves, and Campus Activewear, besides others.
Top stocks to watch today are HDFC Bank, HDFC, Can Fin Homes, Sun Pharma, and RVNL.
Today's stocks to watch: SAIL, Nykaa, Power Finance Corporation, Gujarat Gas, Castrol India, and Campus Activewear will release third-quarter fiscal year (Q3FY23) results.
Sun Pharma Q3 Results: The pharmaceutical company increased its net profit by 5.2% year on year to Rs 2,166 crore in the third quarter ended December 2022.
Stocks to Watch: Find out which businesses are creating news before the market opens.
The pharmaceutical company Sun Pharma reported an increase in consolidated revenue from operations of 13.8%.
Sun Pharmaceutical Industries Limited is the largest Indian multinational company headquartered in Mumbai.
The company reported a stable 70 percent year-on-year growth in profit after tax at Rs 1,813 crore in the second quarter of FY21. This led to a gain of 10 percent in the past two trading days.
Sun Pharma's American arm Taro Pharmaceutical has resolved antitrust cases involving multi-year investigations by US Department of Justice into the country's generic pharmaceutical industry.
Showing 60 of 60 articles